|
Jun 3
|
FDA considers updating COVID boosters, Novavax stock reacts
|
|
Jun 3
|
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
|
|
Jun 1
|
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
|
|
May 27
|
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
|
|
May 24
|
Why Vaccine Stocks Rallied This Week
|